Browse All

Current Filters

CLEAR FILTER x

TITLE

ORATORIO-HAND: Results of the Primary Analysis of Ocrelizumab vs Placebo in Primary Progressive Multiple Sclerosis, Including Older Patients and Those With More Advanced Disease

Humoral Vaccine Responses and One-year Follow-up of Infants Potentially Exposed to Ocrelizumab During Pregnancy and Breastfeeding: Final Analyses of the Prospective, Multicenter, Open-label, Phase IV Studies MINORE and SOPRANINO

Enhancing Traumatic Brain Injury Care Through A Point of Care Precision Medicine Dashboard: Stakeholder-Designed TBI BRIDGE

Linking Real-world Mobility to Molecular Markers of Neuroaxonal Damage in People With Progressive Multiple Sclerosis

Efficient, Scalable Generation of a Real-world Clinical MS Cohort Using LLM: Validation and Applications